AU2003266272A8 - Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) - Google Patents

Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk)

Info

Publication number
AU2003266272A8
AU2003266272A8 AU2003266272A AU2003266272A AU2003266272A8 AU 2003266272 A8 AU2003266272 A8 AU 2003266272A8 AU 2003266272 A AU2003266272 A AU 2003266272A AU 2003266272 A AU2003266272 A AU 2003266272A AU 2003266272 A8 AU2003266272 A8 AU 2003266272A8
Authority
AU
Australia
Prior art keywords
pyruvate kinase
tumour specific
peptide modulators
specific pyruvate
kinase subtype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003266272A
Other versions
AU2003266272A1 (en
Inventor
Gilles Spoden
Barbara Fitzky
Werner Paul Zwerschke
Hendrik Pidder Jansen-Durr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMYNON BIO TECH GmbH
Original Assignee
AMYNON BIO TECH GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AMYNON BIO TECH GmbH filed Critical AMYNON BIO TECH GmbH
Publication of AU2003266272A8 publication Critical patent/AU2003266272A8/en
Publication of AU2003266272A1 publication Critical patent/AU2003266272A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/0104—Pyruvate kinase (2.7.1.40)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003266272A 2002-08-12 2003-08-11 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) Abandoned AU2003266272A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02017791.1 2002-08-12
EP02017791 2002-08-12
PCT/EP2003/008901 WO2004016646A2 (en) 2002-08-12 2003-08-11 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk)

Publications (2)

Publication Number Publication Date
AU2003266272A8 true AU2003266272A8 (en) 2004-03-03
AU2003266272A1 AU2003266272A1 (en) 2004-03-03

Family

ID=31725344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003266272A Abandoned AU2003266272A1 (en) 2002-08-12 2003-08-11 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk)

Country Status (2)

Country Link
AU (1) AU2003266272A1 (en)
WO (1) WO2004016646A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2344453B1 (en) * 2008-10-09 2016-12-28 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
AU2016222539A1 (en) * 2015-02-26 2017-09-28 Proda Biotech Llc Molecules disrupting pyruvate kinase M2 and integrin interaction and uses thereof
EP3775184A1 (en) * 2018-03-29 2021-02-17 F. Hoffmann-La Roche AG Modulating lactogenic activity in mammalian cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838900A1 (en) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula PYRUVATKINASE-ISOENZYM TYPE M2 (TUMOR M2-PK) SPECIFIC ANTIBODIES / METHOD FOR THE PRODUCTION AND USE THEREOF
US6808878B1 (en) * 1996-07-15 2004-10-26 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US6358683B1 (en) * 1999-06-03 2002-03-19 The Regents Of The University Of California Blood-based assays for breast cancer
DE10029131A1 (en) * 2000-06-14 2002-01-03 Ulf R Rapp New nucleic acid encoding protein kinase of the mitogenic signaling pathway, useful for identifying cytostatic agents, includes the sequence of a glycolytic enzyme binding site
DE10112926B4 (en) * 2001-03-13 2005-11-10 Schebo Biotech Ag Use of aminooxyacetate for tumor treatment
DK1390525T3 (en) * 2001-05-23 2008-12-08 Max Planck Gesellschaft Pyrovate kinase as a novel target molecule

Also Published As

Publication number Publication date
WO2004016646A2 (en) 2004-02-26
WO2004016646A3 (en) 2004-12-16
AU2003266272A1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
AU2003237338A1 (en) Plasma projection
GB2388992B (en) Projector with narrow-spectrum light source to complement broad-spectrum light source
GB2387254B (en) User authentication for computer systems
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
EP1475824A4 (en) Plasma film forming system
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2003213583A1 (en) Robust multi-factor authentication for secure application environments
HUP0500851A2 (en) Process for the preparation of rosuvastatin
AU2002340139A1 (en) Inhibitors of the egf receptor for the treatment of thyroid cancer
EP1804804A4 (en) Loxapine analogs and methods of use thereof
AU2003256598A1 (en) Easy gripping face mask
GB2378038B (en) Ion source vaporizer
AU2003272069A1 (en) Novel floating dosage form
PL374401A1 (en) 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
EP1576799A3 (en) Latent effects projection system
AU2003266272A8 (en) Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk)
AU2003260794A1 (en) Immunotherapy using modulators of notch signalling
AU2003248789A8 (en) Direct transaction mode for peripheral devices
GB0116047D0 (en) Peptide motif for therapy
AU2003278420A8 (en) Process for the preparation of ganciclovir
AU2003224327A8 (en) Process for the synthesis of peptides
SI2264049T1 (en) 1-Desamino-8-d-arginyl vasopressin analogs
GB0211817D0 (en) Projection system
AU2003213088A1 (en) Use of melatonin analogues for induction of general anesthesia

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase